Edward P. Gelmann, MD

Professor, Medicine
The John Norton Endowed Chair for Prostate Cancer Research

After becoming an established researcher at the NCI through his work in the molecular biology of solid tumors, Dr. Gelmann moved to Georgetown University where he assumed the role of chief of the Division of Hematology/Oncology. He then headed to Columbia University, where he served as chief of the Division of Hematology/Oncology and then deputy director of the cancer center. He continues his research on the molecular biology of prostate cancer. His laboratory has made major contributions to understanding of the genetic steps that transform a normal prostate cell to a cancer cell.

Dr. Gelmann also remains actively involved in oncology patient care, in pre- and postdoctoral education, and in teaching graduate students, house staff and fellows.

Dr. Gelmann serves as Editor-in-Chief of the journal Endocrine Oncology.

Degree(s)

  • MD: Stanford University School of Medicine, Palo Alto, California, 1972-76
  • BS (magna cum laude): Yale University, New Haven, Connecticut, 1968-72
Residency
University of Chicago Hospitals and Clinics, Internal Medicine, 1976-78
Fellowship
Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, Medical Oncology, 1978-80
Board Certifications
Subspecialty Certification in Medical Oncology, ABIM, 1982
Diplomat in Internal Medicine, American Board of Internal Medicine, 1980
Diplomat, National Board of Medical Examiners, 1977
Honors and Awards
Medical Staff Fellow, Laboratory of Tumor Cell Biology, National Cancer Institute, Bethesda, Md., 1979-83
Medical Scientist Training Program, Stanford University, Palo Alto, Calif., 1976
Scholar of the House (magna cum laude), Yale University, New Haven, Conn., 1972
Clinical Specialties
Genitourinary Malignancies
Prostate Cancer
Testicular Cancer
Bladder Cancer
Renal Cell Cancer
Research Interests

molecular biology of prostate cancer